Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
Evaluate the extent to which treatment of iron deficiency anemia beyond 24-34 weeks'
gestation of pregnancy with intravenous iron increases hemoglobin compared to oral iron. The
investigators will test the hypothesis that pregnant women who are anemic in the second and
third trimester are more likely to significantly increase their hemoglobin with intravenous
iron as opposed to the usual standard of care, oral iron.